The effects of rosiglitazone on insulin resistance and oxidative stress in non-obese patients with polycystic ovary syndrome

Basit Öğe Kaydı
dc.contributor.authorBukan, N.
dc.contributor.authorYilmaz, M.
dc.contributor.authorAyvaz, G.
dc.contributor.authorKarakoç, A.
dc.contributor.authorToruner, F.
dc.contributor.authorÇakir, N.
dc.contributor.authorArslan, M.
dc.date.accessioned2020-06-25T17:40:38Z
dc.date.available2020-06-25T17:40:38Z
dc.date.issued2005
dc.departmentKırıkkale Üniversitesi
dc.descriptionEuropean Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) -- MAY 08-12, 2005 -- Glasgow, SCOTLAND
dc.description.abstract…en_US
dc.description.sponsorshipIFCC, FESCCen_US
dc.identifier.citationclosedAccessen_US
dc.identifier.endpageS257en_US
dc.identifier.issn0009-8981
dc.identifier.startpageS257en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3509
dc.identifier.volume355en_US
dc.identifier.wosWOS:000229250401293
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science Bven_US
dc.relation.ispartofClinica Chimica Acta
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe effects of rosiglitazone on insulin resistance and oxidative stress in non-obese patients with polycystic ovary syndromeen_US
dc.typeConference Object

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Bildiri ve Sunum Koleksiyonu